Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Astellas Pharma Global Development, Inc.

Clinical trials sponsored by Astellas Pharma Global Development, Inc., explained in plain language.

Now part of Astellas Pharma Inc. 4503 TOKYO

A global pharmaceutical company developing innovative medicines, a subsidiary of Astellas Pharma.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 21 Not yet recruiting 1 Not yet finished but already full! 13 Completed 14 Terminated 8

Can a new drug ASP388B take on advanced solid tumors?

Disease control Not yet recruiting

This trial tests an experimental drug called ASP388B, given alone or alongside standard cancer therapies, in people with advanced solid tumors that have spread or cannot be removed by surgery. The study has two parts: the first finds a safe dose, and the second tests that dose in…

Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control

Last updated Jul 30, 2026 00:00 UTC